Laguna Tech USA, Inc.
Laguna Tech USA is developing the ZETA Transcatheter Aortic Valve System, a balloon-expandable valve solution designed for Aortic Regurgitation and Aortic Stenosis.
Funding history
About Laguna Tech USA, Inc.
How much funding has Laguna Tech USA, Inc. raised?
Laguna Tech USA, Inc. has raised $3.3M in total funding. The most recent round was Series A.
Where is Laguna Tech USA, Inc. headquartered?
Laguna Tech USA, Inc. is headquartered in Irvine, CA.
What does Laguna Tech USA, Inc. do?
Laguna Tech USA is developing the ZETA Transcatheter Aortic Valve System, a balloon-expandable valve solution designed for Aortic Regurgitation and Aortic Stenosis.
What problem does Laguna Tech USA, Inc. solve?
Aortic regurgitation has no FDA-approved treatment device in the US, leaving patients reliant on medication (only for mild cases), open-heart surgery, or off-label TAVR devices that carry leak and embolization risks.
What's Laguna Tech USA, Inc.'s solution?
Laguna Tech is developing the ZETA Transcatheter Aortic Valve System, an investigational device now in first-in-human clinical trials, to treat both aortic regurgitation and aortic stenosis.
What makes Laguna Tech USA, Inc. different?
The page describes ZETA as the only balloon-expandable valve solution designed for both aortic regurgitation and stenosis, combining balloon-expandable and self-expanding features with six atraumatic arms and a design aimed at reducing pacemaker rates.
What makes Laguna Tech USA, Inc. notable?
Laguna Tech USA is an Irvine-based transcatheter heart valve company led by CEO Gilbert Madrid; it has raised over $8M, including investment from MedTech Innovator.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
